Literature DB >> 21220178

Screening of OPTN in French familial amyotrophic lateral sclerosis.

Stéphanie Millecamps1, Séverine Boillée, Elodie Chabrol, William Camu, Cécile Cazeneuve, François Salachas, Pierre-François Pradat, Véronique Danel-Brunaud, Nadia Vandenberghe, Philippe Corcia, Nadine Le Forestier, Lucette Lacomblez, Gaëlle Bruneteau, Danielle Seilhean, Alexis Brice, Josué Feingold, Vincent Meininger, Eric LeGuern.   

Abstract

Mutations in OPTN gene encoding optineurin have recently been identified at the homozygote and heterozygote state in Japanese families with slowly progressive amyotrophic lateral sclerosis (ALS). OPTN had previously been involved in adult primary open angle glaucoma (POAG). We sequenced the coding exons of OPTN in 126 French patients with familial ALS (FALS). We identified, at the heterozygote state, the nonsense c.382_383insAG variant (also called 691_692insAG), alternatively reported as a causative mutation for primary open angle glaucoma (POAG) or a rare polymorphism and the new p.Arg96Leu variant in a family with dominant ALS. Western blot experiments on the patients' lymphoblasts showed that the former variant led to a loss of function and the latter did not cause protein accumulation. Our results do not confirm the contribution of OPTN in ALS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220178     DOI: 10.1016/j.neurobiolaging.2010.11.005

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

Review 1.  Cellular and molecular biology of optineurin.

Authors:  Hongyu Ying; Beatrice Y J T Yue
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Amyotrophic lateral sclerosis: an update on recent genetic insights.

Authors:  Yohei Iguchi; Masahisa Katsuno; Kensuke Ikenaka; Shinsuke Ishigaki; Gen Sobue
Journal:  J Neurol       Date:  2013-10-02       Impact factor: 4.849

3.  Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.

Authors:  Cyril Pottier; Kevin F Bieniek; NiCole Finch; Maartje van de Vorst; Matt Baker; Ralph Perkersen; Patricia Brown; Thomas Ravenscroft; Marka van Blitterswijk; Alexandra M Nicholson; Michael DeTure; David S Knopman; Keith A Josephs; Joseph E Parisi; Ronald C Petersen; Kevin B Boylan; Bradley F Boeve; Neill R Graff-Radford; Joris A Veltman; Christian Gilissen; Melissa E Murray; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

Review 4.  Misregulated RNA processing in amyotrophic lateral sclerosis.

Authors:  Magdalini Polymenidou; Clotilde Lagier-Tourenne; Kasey R Hutt; C Frank Bennett; Don W Cleveland; Gene W Yeo
Journal:  Brain Res       Date:  2012-03-03       Impact factor: 3.252

Review 5.  How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?

Authors:  Marka van Blitterswijk; Mariely DeJesus-Hernandez; Rosa Rademakers
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

Review 6.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

7.  The TBK1-binding domain of optineurin promotes type I interferon responses.

Authors:  Netra Pal Meena; Guozhi Zhu; Paul R Mittelstadt; Maria Letizia Giardino Torchia; Marie Pourcelot; Damien Arnoult; Jonathan D Ashwell; Ivana Munitic
Journal:  FEBS Lett       Date:  2016-05-04       Impact factor: 4.124

Review 8.  The role of protein complexes in human genetic disease.

Authors:  L Therese Bergendahl; Lukas Gerasimavicius; Jamilla Miles; Lewis Macdonald; Jonathan N Wells; Julie P I Welburn; Joseph A Marsh
Journal:  Protein Sci       Date:  2019-07-01       Impact factor: 6.725

9.  Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.

Authors:  Serena Lattante; Stéphanie Millecamps; Giovanni Stevanin; Sophie Rivaud-Péchoux; Carine Moigneu; Agnès Camuzat; Sandra Da Barroca; Emeline Mundwiller; Philippe Couarch; François Salachas; Didier Hannequin; Vincent Meininger; Florence Pasquier; Danielle Seilhean; Philippe Couratier; Véronique Danel-Brunaud; Anne-Marie Bonnet; Christine Tranchant; Eric LeGuern; Alexis Brice; Isabelle Le Ber; Edor Kabashi
Journal:  Neurology       Date:  2014-08-06       Impact factor: 9.910

10.  OPTN 691_692insAG is a founder mutation causing recessive ALS and increased risk in heterozygotes.

Authors:  Orly Goldstein; Omri Nayshool; Beatrice Nefussy; Bryan J Traynor; Alan E Renton; Mali Gana-Weisz; Vivian E Drory; Avi Orr-Urtreger
Journal:  Neurology       Date:  2016-01-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.